Literature DB >> 16137684

The tumor suppressor Scrib selectively interacts with specific members of the zyxin family of proteins.

Marleen M R Petit1, Koen R M O Crombez, Hilke B V K Vervenne, Nancy Weyns, Wim J M Van de Ven.   

Abstract

The zyxin family of proteins consists of five members, ajuba, LIMD1, LPP, TRIP6 and zyxin, which localize at cell adhesion sites and shuttle to the nucleus. Previously, we established that LPP interacts with the tumor suppressor Scrib, a member of the leucine-rich repeat and PDZ (LAP) family of proteins. Here, we demonstrate that Scrib also interacts with TRIP6, but not with zyxin, ajuba, or LIMD1. We show that TRIP6 directly binds to the third PDZ domain of Scrib via its carboxy-terminus. Both proteins localize in cell-cell contacts but are not responsible to target each other to these structures. In the course of our experiments, we also characterized the nuclear export signal of human TRIP6, and show that LIMD1 is localized in focal adhesions. The binding between two of zyxin's family members and Scrib links Scrib to a communication pathway between cell-cell contacts and the nucleus, and implicates these zyxin family members in Scrib-associated functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16137684     DOI: 10.1016/j.febslet.2005.08.012

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  The cytoskeletal regulator zyxin is required for viability in Drosophila melanogaster.

Authors:  Patricia J Renfranz; Elizabeth Blankman; Mary C Beckerle
Journal:  Anat Rec (Hoboken)       Date:  2010-09       Impact factor: 2.064

2.  Biotin ligase tagging identifies proteins proximal to E-cadherin, including lipoma preferred partner, a regulator of epithelial cell-cell and cell-substrate adhesion.

Authors:  Christina M Van Itallie; Amber Jean Tietgens; Angel Aponte; Karin Fredriksson; Alan S Fanning; Marjan Gucek; James M Anderson
Journal:  J Cell Sci       Date:  2013-12-11       Impact factor: 5.285

Review 3.  TRIP6: an adaptor protein that regulates cell motility, antiapoptotic signaling and transcriptional activity.

Authors:  Victor T G Lin; Fang-Tsyr Lin
Journal:  Cell Signal       Date:  2011-06-13       Impact factor: 4.315

4.  Cell Adhesion and Transcriptional Activity - Defining the Role of the Novel Protooncogene LPP.

Authors:  Thomas Gp Grunewald; Saskia M Pasedag; Elke Butt
Journal:  Transl Oncol       Date:  2009-08-18       Impact factor: 4.243

5.  Lasp1 gene disruption is linked to enhanced cell migration and tumor formation.

Authors:  Han Zhang; Xunsheng Chen; Wendy B Bollag; Roni J Bollag; Daniel J Sheehan; Catherine S Chew
Journal:  Physiol Genomics       Date:  2009-06-16       Impact factor: 3.107

6.  Characterization of TRIP6-dependent nasopharyngeal cancer cell migration.

Authors:  Jie Fei; Jihong Li; Sunan Shen; Weidong Zhou
Journal:  Tumour Biol       Date:  2013-04-11

Review 7.  Emerging roles for LPP in metastatic cancer progression.

Authors:  Elaine Ngan; Alex Kiepas; Claire M Brown; Peter M Siegel
Journal:  J Cell Commun Signal       Date:  2017-10-13       Impact factor: 5.782

8.  A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression.

Authors:  J N Anastas; T L Biechele; M Robitaille; J Muster; K H Allison; S Angers; R T Moon
Journal:  Oncogene       Date:  2011-12-19       Impact factor: 9.867

9.  Supervillin modulation of focal adhesions involving TRIP6/ZRP-1.

Authors:  Norio Takizawa; Tara C Smith; Thomas Nebl; Jessica L Crowley; Stephen J Palmieri; Lawrence M Lifshitz; Anka G Ehrhardt; Laura M Hoffman; Mary C Beckerle; Elizabeth J Luna
Journal:  J Cell Biol       Date:  2006-07-31       Impact factor: 10.539

10.  PP2A binds to the LIM domains of lipoma-preferred partner through its PR130/B″ subunit to regulate cell adhesion and migration.

Authors:  Veerle Janssens; Karen Zwaenepoel; Carine Rossé; Marleen M R Petit; Jozef Goris; Peter J Parker
Journal:  J Cell Sci       Date:  2016-03-04       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.